INOMAX (NITRIC OXIDE) FOR INHALATION
Company : IKARIA Inc
UMDC Code : 452052
he first of our growing list of critical care therapies is INOMAX, an effective intervention for term and near-term infants who suffer from hypoxic respiratory failure (HRF) associated with pulmonary hypertension.1 Since its commercialization in 2000, we believe that over 450,000 patients have been treated with INOMAX worldwide.2. Our experience with INOMAX has taught us that supporting the critical care treatment community takes more than an effective therapy. It takes a commitment to meeting the specialized needs of this environment. From flying in necessary equipment to emergency drug delivery and middle-of-the-night technical assistance, we do what it takes to extend the benefits of INOMAX to patients in need.
Product URL : http://www.ikaria.com/hcp/inomax.html
Last Updated : 03/16/2013